<?xml version="1.0" encoding="UTF-8"?>
<Evidence xmlns="http://hl7.org/fhir" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://hl7.org/fhir ../../schema/evidence.xsd">
  <id value="example-stroke-3-4half-alteplase-vs-no-alteplase-mRS0-2"/>
  <text>
    <status value="generated" />
    <div xmlns="http://www.w3.org/1999/xhtml">
      <p>
        &quot;Effect of Alteplase vs No alteplase on mRS 0-2 at 90 days in Stroke 3-4.5 hours prior&quot; is a comparative effect estimate.
      </p>
	</div>
  </text>
  <url value="Evidence/example-stroke-3-4half-alteplase-vs-no-alteplase-mRS0-2"/>
  <title value="Effect of Alteplase vs No alteplase on mRS 0-2 at 90 days in Stroke 3-4.5 hours prior"/>
  <status value="draft"/>
  <useContext>
    <code>
      <system value="http://terminology.hl7.org/CodeSystem/usage-context-type"/>
      <code value="focus"/>
    </code>
    <valueCodeableConcept>
      <text value="Stroke"/>
    </valueCodeableConcept>
  </useContext>
  <relatedArtifact>
	<type value="citation"/>
	<label value="Lees 2016"/>
	<display value="Figure 2 Lees 2016"/>
	<citation value="Lees KR, Emberson J, Blackwell L, Bluhmki E, Davis SM, Donnan GA, et al; Stroke Thrombolysis Trialists’ Collaborators Group. Effects of alteplase for acute stroke on the distribution of functional outcomes: a pooled analysis of 9 trials. Stroke. 2016;47:2373-2379. PMID 27507856"/>
	<url value="https://doi.org/10.1161/STROKEAHA.116.013644"/>
  </relatedArtifact>
  <description value="mRS 0-2 at 90 days Odds Ratio 1.2 for Alteplase vs. No Alteplase in patients with acute ischemic stroke 3-4.5 hours prior"/>
  <variableDefinition>
		<variableRole>
			<coding>
				<system value="http://terminology.hl7.org/CodeSystem/variable-role"/>
				<code value="population"/>
				<display value="population"/>
			</coding>
		</variableRole>
		<observed>
			<reference value="EvidenceVariable/Stroke-Thrombolysis-Trialists-2014-2016-IPD-MA-Cohort"/>
			<type value="EvidenceVariable"/>
			<display value="Stroke Thrombolysis Trialists’ 2014-2016 IPD-MA Cohort"/>
		</observed>
		<intended>
			<reference value="Group/AcuteIschemicStroke3-4halfHours"/>
			<type value="Group"/>
			<display value="stroke at 3-4.5 hours"/>
		</intended>
		<directnessMatch>
			<coding>
				<system value="http://terminology.hl7.org/CodeSystem/directness"/>
				<code value="moderate"/>
				<display value="Moderate quality match"/>
			</coding>
		</directnessMatch>
  </variableDefinition>
  <variableDefinition>
		<variableRole>
			<coding>
				<system value="http://terminology.hl7.org/CodeSystem/variable-role"/>
				<code value="measuredVariable"/>
				<display value="measured variable"/>
			</coding>
		</variableRole>
		<observed>
			<reference value="EvidenceVariable/example-mRS0-2-at-90days"/>
			<type value="EvidenceVariable"/>
			<display value="mRS 0-2 at 90 days"/>
		</observed>
		<intended>
			<reference value="EvidenceVariable/example-alive-independent-90day"/>
			<type value="EvidenceVariable"/>
			<display value="Alive and not functionally dependent at 90 days"/>
		</intended>
  </variableDefinition>
  <variableDefinition>
		<variableRole>
			<coding>
				<system value="http://terminology.hl7.org/CodeSystem/variable-role"/>
				<code value="exposure"/>
				<display value="exposure"/>
			</coding>
		</variableRole>
		<observed>
			<reference value="EvidenceVariable/example-alteplase-for-stroke"/>
			<type value="EvidenceVariable"/>
			<display value="Alteplase for Stroke"/>
		</observed>
		<intended>
			<reference value="EvidenceVariable/example-alteplase-for-stroke"/>
			<type value="EvidenceVariable"/>
			<display value="Alteplase for Stroke"/>
		</intended>
  </variableDefinition>
  <variableDefinition>
		<variableRole>
			<coding>
				<system value="http://terminology.hl7.org/CodeSystem/variable-role"/>
				<code value="referenceExposure"/>
				<display value="reference exposure"/>
			</coding>
		</variableRole>
		<observed>
			<reference value="EvidenceVariable/example-no-alteplase"/>
			<type value="EvidenceVariable"/>
			<display value="no alteplase"/>
		</observed>
		<intended>
			<reference value="EvidenceVariable/example-no-alteplase"/>
			<type value="EvidenceVariable"/>
			<display value="no alteplase"/>
		</intended>
  </variableDefinition>
	<synthesisType>
		<coding>
			<system value="http://terminology.hl7.org/CodeSystem/synthesis-type"/>
			<code value="IPD-MA"/>
			<display value="individual patient data meta-analysis"/>
		</coding>
	</synthesisType>
	<studyType>
		<coding>
			<system value="http://terminology.hl7.org/CodeSystem/study-type"/>
			<code value="RCT"/>
			<display value="randomized trial"/>
		</coding>
	</studyType>
	<statistic>
		<statisticType>
			<coding>
				<system value="http://terminology.hl7.org/CodeSystem/statistic-type"/>
				<code value="C16932"/>
				<display value="Odds Ratio"/>
			</coding>
		</statisticType>
		<quantity>
			<value value="1.2"/>
		</quantity>
		<sampleSize>
			<numberOfStudies value="9"/>
		</sampleSize>
		<attributeEstimate>
			<description value="95% CI 1.06 to 1.3"/>
			<type>
				<coding>
					<system value="http://terminology.hl7.org/CodeSystem/attribute-estimate-type"/>
					<code value="C53324"/>
					<display value="Confidence interval"/>
				</coding>
			</type>
			<level value="0.95"/>
			<range>
				<low>
					<value value="1.06"/>
				</low>
				<high>
					<value value="1.3"/>
				</high>
			</range>
		</attributeEstimate>
	</statistic>
	<certainty>
		<description value="Very low certainty due to risk of bias, inconsistency, imprecision, and indirectness"/>
		<type>
			<coding>
				<system value="http://terminology.hl7.org/CodeSystem/certainty-type"/>
				<code value="Overall"/>
				<display value="Overall quality"/>
			</coding>
		</type>
		<rating>
			<coding>
				<system value="http://terminology.hl7.org/CodeSystem/certainty-rating"/>
				<code value="very-low"/>
				<display value="Very low quality"/>
			</coding>
		</rating>
		<subcomponent>
			<type>
				<coding>
					<system value="http://terminology.hl7.org/CodeSystem/certainty-type"/>
					<code value="PublicationBias"/>
					<display value="Publication bias"/>
				</coding>
			</type>
			<rating>
				<coding>
					<system value="http://terminology.hl7.org/CodeSystem/certainty-subcomponent-rating"/>
					<code value="no-concern"/>
					<display value="no serious concern"/>
				</coding>
			</rating>
		</subcomponent>
		<subcomponent>
			<note>
				<text value="IST-3 had inconsistent results and contributed large proportion of data"/>
			</note>
			<type>
				<coding>
					<system value="http://terminology.hl7.org/CodeSystem/certainty-type"/>
					<code value="Inconsistency"/>
					<display value="Inconsistency"/>
				</coding>
			</type>
			<rating>
				<coding>
					<system value="http://terminology.hl7.org/CodeSystem/certainty-subcomponent-rating"/>
					<code value="serious-concern"/>
					<display value="serious concern"/>
				</coding>
			</rating>
		</subcomponent>
		<subcomponent>
			<note>
				<text value="results derived from figure with limited data reported to support the specific effect estimate; derived odds ratio in figure does not match results from rates of mRS 0-2 reported in Supplementary Figure 3b"/>
			</note>
			<type>
				<coding>
					<system value="http://terminology.hl7.org/CodeSystem/certainty-type"/>
					<code value="Imprecision"/>
					<display value="Imprecision"/>
				</coding>
			</type>
			<rating>
				<coding>
					<system value="http://terminology.hl7.org/CodeSystem/certainty-subcomponent-rating"/>
					<code value="serious-concern"/>
					<display value="serious concern"/>
				</coding>
			</rating>
		</subcomponent>
		<subcomponent>
			<note>
				<text value="resuts derived for 3 - 4.5 hours assume data from 0 - 6 hours is informative"/>
			</note>
			<type>
				<coding>
					<system value="http://terminology.hl7.org/CodeSystem/certainty-type"/>
					<code value="Indirectness"/>
					<display value="Indirectness"/>
				</coding>
			</type>
			<rating>
				<coding>
					<system value="http://terminology.hl7.org/CodeSystem/certainty-subcomponent-rating"/>
					<code value="serious-concern"/>
					<display value="serious concern"/>
				</coding>
			</rating>
		</subcomponent>
		<subcomponent>
			<note>
				<text value="results largely influenced by IST-3 trial which was unblinded and ECASS III which had baseline imbalances"/>
			</note>
			<type>
				<coding>
					<system value="http://terminology.hl7.org/CodeSystem/certainty-type"/>
					<code value="RiskOfBias"/>
					<display value="Risk of bias"/>
				</coding>
			</type>
			<rating>
				<coding>
					<system value="http://terminology.hl7.org/CodeSystem/certainty-subcomponent-rating"/>
					<code value="serious-concern"/>
					<display value="serious concern"/>
				</coding>
			</rating>
		</subcomponent>
	</certainty>
</Evidence>
